Chris Gugl

Our mission is to inspire the next generation of healthcare to unlock our full potential and make a positive impact on the world.

docjo, a Swiss digital health company with Germany as first target market, is an early-stage venture company that was established by the founders docdok.health, a pioneering healthcare company with a proven track-record. Our primary objective at docjo is to leverage technology to enhance healthcare outcomes. To that end, we have embraced the concept of Software as a Medical Device (SaMD) and have designed a range of applications aimed at helping patients manage and cope with chronic medical conditions. Our ultimate goal is to equip patients and healthcare providers with effective tools and solutions that not only increase efficiency and reduce costs but also increase the overall quality of care.

At Citus we reinvent the characterization of soft materials. Our device, the Nimble, is an aspiration device exceeding current industry standards on sensitivity and accuracy. The Nimble is clinically proven and its well designed shape allows for measurements on difficult locations and various materials. Get in touch for more information l!

We are a digital health startup company in the field of AI-based voice biomarkers and collaborate with global corporate partners, researchers and clinics. Our solution is a unique fully automated continuous ambulatory cough detector. It provides longitudinal 24/7 cough profiles and contextual data at high convenience for investigators and their patients. The results of our clinical validation study (www.ClinicalTrials.gov / NCT04861155) are published and can be found at ERJ open research: https://lnkd.in/ebZrhkMu

Carity is a blended digital health intervention and coach actively used during cardiac rehabilitation that also smoothly accompanies the patient afterward. Carity gives patients back their confidence and motivation so that they can accomplish their personal therapy goals while achieving long-term cardiovascular health improvement.

“Increasing the effectiveness of adherence interventions may have a far greater impact on the health of the population than any improvement in specific medical treatments.” (WHO, 2003) We are a digital adherence start-up focusing on improving therapy compliance of chronically ill patients by applying behavioural economics principles. We combine human engagement with scalable algorithms and use the most relevant gamification factors: fun, friends and feedback. Patients can earn money by following their therapy plan, answering health quizzes or updating their vitals. Financial, social, and motivational incentives help kickstart behaviour change and form long-lasting habits.

Our mission is to inspire the next generation of healthcare to unlock our full potential and make a positive impact on the world.

docjo, a Swiss digital health company with Germany as first target market, is an early-stage venture company that was established by the founders docdok.health, a pioneering healthcare company with a proven track-record. Our primary objective at docjo is to leverage technology to enhance healthcare outcomes. To that end, we have embraced the concept of Software as a Medical Device (SaMD) and have designed a range of applications aimed at helping patients manage and cope with chronic medical conditions. Our ultimate goal is to equip patients and healthcare providers with effective tools and solutions that not only increase efficiency and reduce costs but also increase the overall quality of care.

At Citus we reinvent the characterization of soft materials. Our device, the Nimble, is an aspiration device exceeding current industry standards on sensitivity and accuracy. The Nimble is clinically proven and its well designed shape allows for measurements on difficult locations and various materials. Get in touch for more information l!

DigeHealth is a medtech company that has the goal to revolutionize gastro-enterology. Our solution is a 24h/7 monitoring system that provides relief for patients suffering from bowel obstruction. It is designed to detect bowel obstructions at an early stage. This can significantly reduce the need for surgeries and prevent potential complications. This not only enhances the overall quality of life for patients but also saves lives, particularly among vulnerable populations such as the elderly and infants. Our ability to continuously collect and analyze data means it can be adapted for the early detection and management of a range of medical conditions. Our ambition reaches beyond bowel obstruction—we aspire to become the go-to device for bowel disorders.

We are a digital health startup company in the field of AI-based voice biomarkers and collaborate with global corporate partners, researchers and clinics. Our solution is a unique fully automated continuous ambulatory cough detector. It provides longitudinal 24/7 cough profiles and contextual data at high convenience for investigators and their patients. The results of our clinical validation study (www.ClinicalTrials.gov / NCT04861155) are published and can be found at ERJ open research: https://lnkd.in/ebZrhkMu